Key takeaways:
Glaucoma is a group of eye conditions that damage the optic nerve. Without treatment, glaucoma causes permanent vision loss.
Cannabis can lower eye pressure for a short time. Experts don’t recommend taking cannabis for glaucoma because of side effects.
Cannabis can’t replace traditional treatments for glaucoma. Researchers are looking at whether cannabis can be a complementary therapy for glaucoma.
Cannabis (marijuana) can help treat several medical conditions. For almost 50 years, researchers have been studying whether cannabis can treat glaucoma.
Glaucoma is a group of eye conditions that damage the optic nerve, which sends signals from the eye to the brain. Damage to the optic nerve leads to permanent vision loss. Some people with glaucoma have high pressure inside their eyes. This causes optic nerve damage.
Early research showed that cannabis can lower eye pressure. But newer studies have lessened the promise of cannabis for glaucoma treatment. If you have glaucoma and are trying to decide whether to try cannabis, here’s what you need to know about cannabis and glaucoma.
Wise Cannabis Use Is Here
Get personalized, ongoing product, dose & time of use guidance with our clinician-managed plans. Just $14 a month.
Must be 21 years or older to purchase. Cannabis is not recommended for women who are pregnant or nursing or those who are suffering from bipolar disorder or schizophrenia. Cannabis use may increase risk of falls. Always consult with your doctor before beginning any new medical treatment.
No. Experts at the American Academy of Ophthalmology and the American Glaucoma Society do not recommend cannabis for glaucoma treatment. These experts cite studies showing that cannabis treatment is unreliable and comes with many side effects.
But even with this clear advice, many sources still showcase cannabis as a treatment for glaucoma. So where did this idea come from?
High pressure inside the eye causes some types of glaucoma. Early studies showed that smoking cannabis lowered pressure inside the eye by up to 30%. This led experts to look into whether it could treat glaucoma.
Roadblocks popped up right away.
Cannabis didn’t work for everyone. Only about 60% of people had lower pressure inside the eye after inhaling cannabis. And even then, the effect only lasted 3 to 4 hours.
Eye pressure needs to stay normal throughout the day and night to prevent vision loss. To control eye pressure 24 hours a day, people need to inhale a lot of cannabis. Studies estimate that you would need 18 mg to 20 mg of THC (tetrahydrocannabinol) at least 6 times per day.
Taking this amount of THC every day isn’t practical. And smoking or vaping this much cannabis would also harm the lungs and increase the risk of developing lung cancer. Inhaled cannabis is also expensive. Experts estimate that on average people would spend about $700 each month.
Researchers looked at whether cannabinoid eye drops could be a safer alternative. While these eye drops lowered pressure inside the eye, the effect didn’t last long. And to get picked up by the eye, the cannabinoids had to be dissolved in mineral oil. This made the eye drops too irritating for most people. Newer cannabis eye drops are dissolved in different oils that are less irritating. But these eye drops are still being studied and aren’t available yet.
In the 1970s, cannabis was a good option compared to other available glaucoma treatments. But that’s no longer the case. Today, glaucoma eye drops are affordable and reliable, and they cause fewer side effects. Plus, people only need to use them between one to three times per day.
It’s unclear. Cannabis may worsen glaucoma. This is another reason that experts don’t recommend using it.
Cannabis lowers blood pressure in the eye and lessens blood flow to the optic nerve. Less blood flow can cause more optic nerve damage and worsen glaucoma.
It’s not clear if there’s a dose of cannabis that can lower eye pressure without lowering blood flow to the optic nerve. So experts can’t offer guidance on how much cannabis people can safely take if they have glaucoma.
There’s not a lot of solid evidence that taking cannabis helps glaucoma. But this may change as more research becomes available.
There’s evidence that cannabis may promote fluid movement inside the eye. There’s also some evidence that cannabinoids have antioxidant properties that can help protect the optic nerve. But researchers are quick to point out that these things have only been shown during lab experiments and not in humans.
These findings alone aren’t enough for experts to recommend cannabis as a treatment option for glaucoma. But if you're looking for a complementary treatment for glaucoma, talk to your ophthalmologist about whether cannabis is an option for you.
Cannabis lowers pressure inside the eye, but this effect doesn’t last long. Experts agree that people shouldn’t use cannabis instead of better-studied options for glaucoma treatment. Cannabis can cause unwanted side effects and may even worsen glaucoma. If you’re interested in taking cannabis along with other glaucoma therapies, talk to your healthcare provider about how to add it to your treatment plan.
American Academy of Ophthalmology. (2022). Cannabinoids for glaucoma.
Graul, T. A. (2018). Marijuana and glaucoma. Glaucoma Today.
Jamel, H. D. (2022). Should you be smoking marijuana to treat your glaucoma? Glaucoma Research Foundation.
Jampel, H. (2010). American glaucoma society position statement: Marijuana and the treatment of glaucoma. Journal of Glaucoma.
Mack, A., et al. (2000). Marijuana and medicine: The science behind the controversy. National Academies Press.
Merritt, J. C., et al. (1980). Effect of marihuana on intraocular and blood pressure in glaucoma. Ophthalmology.
Mosaed, S. (2022). Cannabis, glaucoma and intraocular pressure. Review of Ophthalmology.
Novack, G. D. (2016). Cannabinoids for treatment of glaucoma. Current Opinion in Ophthalmology.
Tomida, I., et al. (2004). Cannabinoids and glaucoma. British Journal of Ophthalmology.
Turbert, D., et al. (2022). Does marijuana help treat glaucoma or other eye conditions? American Academy of Ophthalmology.